|Articles|July 1, 2005

Pharmacy Times

  • Volume 0
  • 0

Testosterone Boosts Posthysterectomy Libido

Investigators have found that libido lost following hysterectomy may be regained after theuse of a testosterone patch for 24 weeks. Because the ovaries are a significant source oftestosterone in women, their removal can cause up to a 50% loss of libido.

By keeping a log of their sexual activity, women using a testosterone patch reported havingone extra satisfying sexual encounter every 2.5 weeks, compared with one every 5.5 weeksin the placebo group. Side effects were reported among both groups, although the testosteronegroup reported acne and deeper voices—common effects of male hormones. Testosteronepatch users indicated improvements in desire, arousal, pleasure, orgasms, responsiveness,and self-image, as well as less personal distress, compared with placebo users.Procter & Gamble Pharmaceuticals funded the study; the company is currently developing thefemale testosterone patch Instrinsa.

Articles in this issue

over 21 years ago

Calcium: An Essential Mineral

over 21 years ago

CAN YOU READTHESE Rxs?

over 21 years ago

ECKEL RECEIVES ALUMNI AWARD

over 21 years ago

Cancer: Update on Biologics

over 21 years ago

PHARMACIST'S RIGHT TO CHOOSE?

over 21 years ago

Teenage Drug Diversion—Part 2

over 21 years ago

Is Altering Refills a Criminal Act?

over 21 years ago

Do All SSRIs Interact the Same Way?

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe

Related to this article

mRNA vaccine bottles and syringes for preventing coronavirus or covid-19 - Image credit: kitsawet | stock.adobe.com
Despite the controversy surrounding mRNA's role in the COVID-19 response, the technology's broader promise—to prevent, treat, and even cure a host of diseases—is coming into focus.